Fredun Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	197.39	156.23	108.07	63.35	20.15
Depreciation & Amortization	49.14	37.42	27.65	21.33	19.82
Other Amortization	1.26	0.54	0.44	0.24	0.22
Other Operating Activities	303.08	187.99	155.43	79	66.47
Change in Accounts Receivable	-1,123	-302.89	557.13	-491.98	-21.01
Change in Inventory	-648.91	-248.74	-1,037	211.14	-171.13
Change in Accounts Payable	818.41	36.04	107.26	-113.44	137.37
Change in Income Taxes	15.81	12.45	-27.91	-5.45	-21.99
Change in Other Net Operating Assets	95.92	116.57	-35.53	212	-28.2
Operating Cash Flow	-290.63	-4.39	-144.09	-23.8	1.7
Capital Expenditures	-61.06	-76.39	-94.95	-42.86	-13.88
Sale of Property, Plant & Equipment	1.12	-	0.9	1.43	-
Investment in Securities	-3.6	-	-	-	-
Investing Cash Flow	-63.54	-76.39	-94.05	-41.43	-13.88
Short-Term Debt Issued	640.82	216.05	271.78	1.97	-
Long-Term Debt Issued	-	-	68.89	129.29	176.15
Total Debt Issued	640.82	216.05	340.67	131.25	176.15
Short-Term Debt Repaid	-	-	-	-	-128.71
Long-Term Debt Repaid	-24.45	-26.42	-	-	-
Total Debt Repaid	-24.45	-26.42	-	-	-128.71
Net Debt Issued (Repaid)	616.37	189.63	340.67	131.25	47.44
Issuance of Common Stock	0.33	-	-	-	-
Other Financing Activities	-225.53	-129.7	-88.9	-56.58	-54.57
Financing Cash Flow	391.16	59.93	251.77	74.67	-7.13
Miscellaneous Cash Flow Adjustments	0	-0	-0	-	0
Net Cash Flow	36.99	-20.85	13.63	9.44	-19.31
Free Cash Flow	-351.69	-80.78	-239.03	-66.66	-12.18
Free Cash Flow Margin	-7.75%	-2.32%	-8.70%	-2.97%	-0.91%
Free Cash Flow Per Share	-75.76	-17.40	-53.38	-16.05	-3.05
Cash Interest Paid	223.77	136.5	92.82	46.69	41.62
Levered Free Cash Flow	-551.15	-269.38	-445.24	-337.49	-79.01
Unlevered Free Cash Flow	-423.5	-191.14	-397.98	-310.05	-55.02
Change in Working Capital	-841.49	-386.57	-435.68	-187.73	-104.95

Source: S&P Global Market Intelligence. Standard template. Financial Sources.